Cargando…

Von Willebrand's disease: case report and review of literature

Von Willebrand Disease (VWD) is the most common human inherited bleeding disorder due to a defect of Von Willebrand Factor (VWF), which a glycoprotein crucial for platelet adhesion to the subendothelium after vascular injury. VWD include quantitative defects of VWF, either partial (type 1 with VWF l...

Descripción completa

Detalles Bibliográficos
Autores principales: Echahdi, Hanae, El Hasbaoui, Brahim, El Khorassani, Mohamed, Agadr, Aomar, Khattab, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567960/
https://www.ncbi.nlm.nih.gov/pubmed/28904675
http://dx.doi.org/10.11604/pamj.2017.27.147.12248
_version_ 1783258786621816832
author Echahdi, Hanae
El Hasbaoui, Brahim
El Khorassani, Mohamed
Agadr, Aomar
Khattab, Mohamed
author_facet Echahdi, Hanae
El Hasbaoui, Brahim
El Khorassani, Mohamed
Agadr, Aomar
Khattab, Mohamed
author_sort Echahdi, Hanae
collection PubMed
description Von Willebrand Disease (VWD) is the most common human inherited bleeding disorder due to a defect of Von Willebrand Factor (VWF), which a glycoprotein crucial for platelet adhesion to the subendothelium after vascular injury. VWD include quantitative defects of VWF, either partial (type 1 with VWF levels < 50 IU/dL) or virtually total (type 3 with undetectable VWF levels) and also qualitative defects of VWF (type 2 variants with discrepant antigenic and functional VWF levels). The most bleeding forms of VWD usually do not concern type 1 patients with the mildest VWF defects (VWF levels between 30 and 50IU/dL). Von willebrand factor is a complex multimeric protein with two functions: it forms a bridge between the platelets and areas of vascular damage and it binds to and stabilizes factor VIII, which is necessary for the clotting cascade. By taking a clinical history of bleeding (mucocutaneous bleeding symptoms suggestive of a primary haemostatic disorder, a quantitative or qualitative abnormality of VWF is possible) it is important to think about VWD and to make the appropriate diagnosis. If the VWD is suspected diagnostic tests should include an activated partial thromboplastin time, bleeding time, factor VIII: C Ristocetin cofactor and vWF antigen. Additional testing of ristocetin induced plattlet adhesion (RIPA) the multimeric structure and collagen binding test and genanalysis allow diagnosing the different types of von. Willebrand Disease. The treatment of choice in mild forms is the synthetic agent desmopressin. In patients with severe type 1, type 2B, 2N and type 3 or in people who do not response to desmopressin, the appropriate treatment is a factor VIII concentrate that is rich of VWF. We report a case of infant in 27-month-old boy who had been referred due to haemorrhagic shock. His birth histories, his familie's social history and developmental milestones were unremarkable. He was born at full term with no antenatal or perinatal complications. Prior to the symptoms, the child was on a normal diet and was thriving appropriately. The child presented one days before his admission trauma to the inner face of the lower lip that caused an external acute bleeding loss. The laboratory data showed unfortunately, the most severe form of Von Willebrand's Disease; Type 3. The management was based on erythrocyte and fresh-frozen plasma (FFP) transfusions with administration of factor VII with good evolution.
format Online
Article
Text
id pubmed-5567960
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The African Field Epidemiology Network
record_format MEDLINE/PubMed
spelling pubmed-55679602017-09-13 Von Willebrand's disease: case report and review of literature Echahdi, Hanae El Hasbaoui, Brahim El Khorassani, Mohamed Agadr, Aomar Khattab, Mohamed Pan Afr Med J Case Report Von Willebrand Disease (VWD) is the most common human inherited bleeding disorder due to a defect of Von Willebrand Factor (VWF), which a glycoprotein crucial for platelet adhesion to the subendothelium after vascular injury. VWD include quantitative defects of VWF, either partial (type 1 with VWF levels < 50 IU/dL) or virtually total (type 3 with undetectable VWF levels) and also qualitative defects of VWF (type 2 variants with discrepant antigenic and functional VWF levels). The most bleeding forms of VWD usually do not concern type 1 patients with the mildest VWF defects (VWF levels between 30 and 50IU/dL). Von willebrand factor is a complex multimeric protein with two functions: it forms a bridge between the platelets and areas of vascular damage and it binds to and stabilizes factor VIII, which is necessary for the clotting cascade. By taking a clinical history of bleeding (mucocutaneous bleeding symptoms suggestive of a primary haemostatic disorder, a quantitative or qualitative abnormality of VWF is possible) it is important to think about VWD and to make the appropriate diagnosis. If the VWD is suspected diagnostic tests should include an activated partial thromboplastin time, bleeding time, factor VIII: C Ristocetin cofactor and vWF antigen. Additional testing of ristocetin induced plattlet adhesion (RIPA) the multimeric structure and collagen binding test and genanalysis allow diagnosing the different types of von. Willebrand Disease. The treatment of choice in mild forms is the synthetic agent desmopressin. In patients with severe type 1, type 2B, 2N and type 3 or in people who do not response to desmopressin, the appropriate treatment is a factor VIII concentrate that is rich of VWF. We report a case of infant in 27-month-old boy who had been referred due to haemorrhagic shock. His birth histories, his familie's social history and developmental milestones were unremarkable. He was born at full term with no antenatal or perinatal complications. Prior to the symptoms, the child was on a normal diet and was thriving appropriately. The child presented one days before his admission trauma to the inner face of the lower lip that caused an external acute bleeding loss. The laboratory data showed unfortunately, the most severe form of Von Willebrand's Disease; Type 3. The management was based on erythrocyte and fresh-frozen plasma (FFP) transfusions with administration of factor VII with good evolution. The African Field Epidemiology Network 2017-06-29 /pmc/articles/PMC5567960/ /pubmed/28904675 http://dx.doi.org/10.11604/pamj.2017.27.147.12248 Text en © Hanae Echahdi et al. http://creativecommons.org/licenses/by/2.0/ The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Echahdi, Hanae
El Hasbaoui, Brahim
El Khorassani, Mohamed
Agadr, Aomar
Khattab, Mohamed
Von Willebrand's disease: case report and review of literature
title Von Willebrand's disease: case report and review of literature
title_full Von Willebrand's disease: case report and review of literature
title_fullStr Von Willebrand's disease: case report and review of literature
title_full_unstemmed Von Willebrand's disease: case report and review of literature
title_short Von Willebrand's disease: case report and review of literature
title_sort von willebrand's disease: case report and review of literature
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567960/
https://www.ncbi.nlm.nih.gov/pubmed/28904675
http://dx.doi.org/10.11604/pamj.2017.27.147.12248
work_keys_str_mv AT echahdihanae vonwillebrandsdiseasecasereportandreviewofliterature
AT elhasbaouibrahim vonwillebrandsdiseasecasereportandreviewofliterature
AT elkhorassanimohamed vonwillebrandsdiseasecasereportandreviewofliterature
AT agadraomar vonwillebrandsdiseasecasereportandreviewofliterature
AT khattabmohamed vonwillebrandsdiseasecasereportandreviewofliterature